Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

227

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

227 results for “CVD”

Learn how ShareScore rates datasets ↗
zenodo44/100

Dataset for "CVD growth of self-assembled 2D and 1D WS2 nanomaterials for the ultrasensitive detection of NO2"

<p>This file contains the raw data used in the paper entitled CVD growth of self-assembled 2D and 1D WS2 nanomaterials for the ultrasensitive detection of NO2 published in Sensors and Actuators: B. Chemical 326 (2021) 128813</p> <p>DOI: <a href="https://doi.org/10.1016/j.snb.2020.128813">10.1016/j.snb.2020.128813</a></p>

opencc-by-4.0Jan 2022View details →
zenodo44/100

Data of the publication Optimizing ion implantation to create shallow NV centre ensembles in high-quality CVD diamond

<p>Data of the publication&nbsp;published by&nbsp;IOP under the reference:&nbsp;Midrel Wilfried Ngandeu Ngambou&nbsp;<em>et al</em>&nbsp;2022&nbsp;<em>Mater. Quantum. Technol.</em>&nbsp;<strong>2</strong>&nbsp;045001 .</p>

opencc-by-4.0May 2023View details →
zenodo40/100

Dataset: CVD Equipment Corporation (CVV) Stock Performance

This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.

opencc-zeroJun 2024View details →
zenodo40/100

Limma-voom differential expression results for GTEx CVD and MD analyses

<p>Supplementary File 5 for the paper entitled &quot;Exploring the Impact of Cerebrovascular Disease and Major Depression on Non-diseased Human Tissue Transcriptomes&quot; (doi: 10.3389/fgene.2021.696836).</p>

opencc-by-4.0Jul 2021View details →
dryad36/100

Risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry

<p>Context</p> <p>Cardiovascular disease (CVD) is a major cause of mortality in adults with type 1 diabetes.</p> <p>Objective</p> <p>We prospectively evaluated CVD risk factors in a large, contemporary cohort of adults with type 1 diabetes living in the United States.</p> <p>Design</p> <p>Observational study of CVD and CVD risk factors over a median of 5.3 years.</p> <p>Setting</p> <p>The T1D Exchange clinic network.</p> <p>Patients</p> <p>Adults (age ≥18 years) with type 1 diabetes and without known CVD diagnosed before or at enrollment.</p> <p>Main Outcome Measure</p> <p>Associations between CVD risk factors and incident CVD were assessed by multivariable logistic regression.</p> <p>Results</p> <p>The study included 8,727 participants (53% female, 88% non-Hispanic white, median age 33 years [IQR=21, 48], type 1 diabetes duration 16 years [IQR=9, 26]). At enrollment, median HbA1c was 7.6% (66 mmol/mol) [IQR=6.9 (52), 8.6 (70)], 33% used a statin, and 37% used blood pressure medication. Over a mean follow-up of 4.6 years, 325 (3.7%) participants developed incident CVD. Ischemic heart disease was the most common CVD event. Increasing age, BMI, HbA1c, presence of hypertension and dyslipidemia, increasing duration of diabetes, and diabetic nephropathy were associated with increased risk for CVD. There were no significant gender differences in CVD risk.</p> <p>Conclusion</p> <p>HbA1c, hypertension, dyslipidemia and diabetic nephropathy are important risk factors for CVD in adults with type 1 diabetes. A longer follow-up is likely required to assess the impact of other traditional CVD risk factors on incident CVD in the current era.</p>

opencc-zeroMar 2020View details →
zenodo36/100

Color vision deficiency (CVD)

<p>The <strong>color vision deficiency</strong> dataset is designed to train and evaluate a deep neural network for image recoloring aimed at compensating for color vision deficiencies, specifically protanopia and deuteranopia. The dataset contains two types of images:</p> <ol> <li><strong>Natural Scene Images</strong>: These are photographs of real-world scenes, filtered to include images with colors that are confusing or difficult to distinguish for individuals with color vision deficiencies.</li> <li><strong>Artificial Images</strong>: These are generated images that feature color pairs specifically known to be confusing for those with protanopia and deuteranopia. The images are created by selecting color pairs from the RGB space and generating patterns designed to highlight these confusing colors.</li> </ol> <p>This dataset is used to train a neural network, employing the Swin transformer architecture, to enhance contrast and maintain naturalness in images for individuals with these types of color vision deficiencies</p>

opencc-by-4.0Oct 2024View details →
zenodo36/100

Deliverable 1.3 Growth of hBN via CVD as a high-mobility substrate

<p>The growth of hBN is explored via CVD on Ni, using a tubular reactor and ammonia borane as precursors. The parameter space was explored and hBN was successfully grown. This deliverable reports the recipe and growth of hBN via CVD, and a complete and extensive characterization with Optical Microscopy (OM), X-Ray Photoelectron Spectroscopy (XPS), Electron Energy Loss Spectra (EELS) and Transmission Electron Microscopy (TEM). Two different 10x10mm2 samples from different areas of a 4&rsquo; wafer sample were analysed by OM and XPS, and two other areas where transferred to TEM grids for TEM characterization (4 samples in total with complementary techniques).</p>

opencc-by-4.0Dec 2020View details →
ClinicalTrials.gov36/100

Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD)

ClinicalTrials.gov study NCT03385239. IPD Sharing: NO. Countries: 2. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV

ClinicalTrials.gov study NCT04661813. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

ClinicalTrials.gov study NCT04023552. IPD Sharing: YES. Countries: 43. Publications: 8.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia

ClinicalTrials.gov study NCT02147626. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

ClinicalTrials.gov study NCT02458690. IPD Sharing: Not stated. Countries: 1. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

ClinicalTrials.gov study NCT04786457. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women

ClinicalTrials.gov study NCT01048606. IPD Sharing: Not stated. Countries: 1. Publications: 12.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk

ClinicalTrials.gov study NCT04431960. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Reducing CVD Risk in Caregivers: A Brief Behavioral Activation Intervention

ClinicalTrials.gov study NCT01802554. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk

ClinicalTrials.gov study NCT01346189. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction

ClinicalTrials.gov study NCT00938340. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?

ClinicalTrials.gov study NCT03001713. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

ClinicalTrials.gov study NCT00632021. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record